Paradigm Medical Industries (PDMI) Stock Analysis & Winston Score

Paradigm Medical Industries makes diagnostic equipment for eye doctors. Its main product is the Paradigm C-Scan, a device that maps the surface of the cornea — the clear front part of the eye — to help doctors detect and monitor conditions like keratoconus and other corneal diseases. The company sells primarily to ophthalmologists and optometrists in clinical settings.

Paradigm generates revenue by selling its diagnostic hardware and related accessories directly to eye care practices. It is a very small company, with a market cap near zero, and operates mainly in the United States. Despite a high gross margin, the deeply negative return on invested capital signals the business is not efficiently converting investment into profit. The key risk is its tiny scale: with limited resources, Paradigm faces significant competition from larger, better-funded medical device makers and may struggle to expand its customer base or fund ongoing product development.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-33.2% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+97.8% YoY

YoY Growth Rate

Strong earnings growth

Insider Activity

0.0%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~2 months

$44,000 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

Paradigm Medical Industries has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

53.6%

Healthy — 53.6% gross margin

Operating Margin

102.0%

Excellent — 102.0% operating margin

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-30.7%

Shrinking sales (-30.7% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-25.0%

Burning cash (-25.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

6.49x

Adequate interest coverage (6.5x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial